Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2019 | The role of the advanced nurse practioner in CAR T-cell therapy

Jenai Wilmoth • 26 Mar 2019
EBMT 2019
Acute Lymphoblastic Leukemia Chronic Lymphocytic Leukemia Leukemia Lymphoma Multiple Myeloma CAR-T

Here, Jenai Wilmoth, RN, of UCSF Medical Center, San Francisco, CA, discusses the important role the advanced nurse practioner plays in the management of patients undergoing CAR T-cell therapy. Ms Wilmoth was speaking at the European Society for Blood and Marrow Transplantation (EBMT) 2019 Annual Meeting, held in Frankfurt, Germany.

Related Videos

1:40
The role of CPX-351 in the AML treatment landscape & insights into the AMLSG 30-18 trial
Felicitas Thol • 19 Apr 2024
3:21
Integrating genomics and MRD in transplant decision-making for patients with AML
Jurjen Versluis • 22 Apr 2024
4:19
Blinatumomab to achieve remission and consolidation with haploSCT for pediatric ALL
Alberto Olaya-Vargas • 15 Apr 2024
3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals